Clinical Trial Update: Wumeiwan Jiawei Fang Use in Patients With Blepharospasm [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Wumeiwan Jiawei Fang in blepharospasm indicates ongoing Phase 2/Phase 3 exploration for related conditions, with no status available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Dry Eye Syndromes
• Hyperactivity
• Meige Syndrome

Drugs mentioned

• Wumeiwan Jiawei Fang

Snippet

Sponsor: China Academy of Chinese Medical Sciences | Conditions: Dry Eye Syndromes, Meige Syndrome | Phase 2, Phase 3 | Status: UNKNOWN